Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1244254 | 0.85 | USP2 (0.35) | USP2HTTSPHK1LPAR5HSD17B10 | |
| SCHEMBL1244321 | 0.85 | LMNA (0.43) | USP2HTTSPHK1LMNALPAR5 | |
| SCHEMBL12621160 | 0.82 | USP2 (0.40) | USP2HTTLPAR5HSD17B10CYP1A2 | |
| SCHEMBL1245261 | 0.81 | HTT (0.53) | USP2HTTLPAR5CYP1A2CYP3A4 | |
| SCHEMBL1244943 | 0.80 | USP2 (0.35) | USP2SPHK1 | |
| SCHEMBL12621165 | 0.80 | SPHK1 (0.33) | USP2HTTSPHK1 | |
| SCHEMBL27965038 | 0.78 | HSD17B10 (0.45) | USP2HTTSPHK1HSD17B10 | |
| SCHEMBL1245101 | 0.76 | ADRB1 (0.42) | HTTLMNACYP1A2 | |
| SCHEMBL14507020 | 0.76 | USP2 (0.35) | USP2HTTSPHK1HIF1ALMNA | |
| SCHEMBL258455 | 0.76 | USP2 (0.55) | USP2HTTSPHK1HIF1ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2124545-B1 | HYDROLYSIS RESISTANT ORGANOMODIFIED SILYLATED IONIC SURFACTANTS | MOMENTIVE PERFORMANCE MAT INC (US) | 2015-12-02 | — | — | EP | disclosed |
| EP-2124545-B1 | HYDROLYSIS RESISTANT ORGANOMODIFIED SILYLATED IONIC SURFACTANTS | MOMENTIVE PERFORMANCE MAT INC (US) | 2015-12-02 | — | — | EP | disclosed |
| US-8569385-B2 | Hydrolysis resistant organomodified silylated ionic surfactants | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2013-10-29 | — | — | US | disclosed |
| US-8569385-B2 | Hydrolysis resistant organomodified silylated ionic surfactants | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2013-10-29 | — | — | US | disclosed |
| US-8569385-B2 | Hydrolysis resistant organomodified silylated ionic surfactants | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2013-10-29 | — | — | US | disclosed |
| US-20110105428-A1 | HYDROLYSIS RESISTANT ORGANOMODIFIED SILYLATED IONIC SURFACTANTS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2011-05-05 | — | — | US | disclosed |
| US-20110105428-A1 | HYDROLYSIS RESISTANT ORGANOMODIFIED SILYLATED IONIC SURFACTANTS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2011-05-05 | — | — | US | disclosed |
| US-7879916-B2 | Anionic, cationic or zwitterionic disilane surfactants; stable over a wide pH range; for controlling wetting, spreading, foaming, and detergency on applied surfaces; aqueous solutions improve delivery of active ingredients | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2011-02-01 | — | — | US | disclosed |
| US-7879916-B2 | Anionic, cationic or zwitterionic disilane surfactants; stable over a wide pH range; for controlling wetting, spreading, foaming, and detergency on applied surfaces; aqueous solutions improve delivery of active ingredients | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2011-02-01 | — | — | US | disclosed |
| EP-2124545-A1 | HYDROLYSIS RESISTANT ORGANOMODIFIED SILYLATED IONIC SURFACTANTS | Momentive Performance Materials Inc. (US) | 2009-12-02 | — | — | EP | disclosed |
| EP-2124544-A1 | HYDROLYSIS RESISTANT ORGANOMODIFIED SILYLATED IONIC SURFACTANTS | Momentive Performance Materials Inc. (US) | 2009-12-02 | — | — | EP | disclosed |
| US-20080167389-A1 | Hydrolysis resistant organomodified silylated ionic surfactants | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2008-07-10 | — | — | US | disclosed |
| US-20080167389-A1 | Hydrolysis resistant organomodified silylated ionic surfactants | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2008-07-10 | — | — | US | disclosed |
| US-20080167269-A1 | HYDROLYSIS RESISTANT ORGANOMODIFIED SILYLATED IONIC SURFACTANTS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2008-07-10 | — | — | US | disclosed |
| US-20080167269-A1 | HYDROLYSIS RESISTANT ORGANOMODIFIED SILYLATED IONIC SURFACTANTS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2008-07-10 | — | — | US | disclosed |
| WO-2008073397-A1 | HYDROLYSIS RESISTANT ORGANOMODIFIED SILYLATED IONIC SURFACTANTS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2008-06-19 | — | — | WO | disclosed |
| WO-2008073396-A1 | HYDROLYSIS RESISTANT ORGANOMODIFIED SILYLATED IONIC SURFACTANTS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2008-06-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110105428-A1 | HYDROLYSIS RESISTANT ORGANOMODIFIED SILYLATED IONIC SURFACTANTS | MLNR, SSTR3, FOXM1 | USP2 664/4885HTT 2729/4885SPHK1 1919/4885 |
| US-20080167389-A1 | Hydrolysis resistant organomodified silylated ionic surfactants | MLNR, SSTR3, FOXM1 | USP2 664/4885HTT 2729/4885SPHK1 1919/4885 |
| US-20080167269-A1 | HYDROLYSIS RESISTANT ORGANOMODIFIED SILYLATED IONIC SURFACTANTS | MLNR, SSTR3, FOXM1 | USP2 664/4885HTT 2729/4885SPHK1 1919/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.